Articles tagged with “nsclc”

GSK Nuvalent Acquisition: ROS1/ALK NSCLC TKI Pipeline

Analyze GSK’s $10.6B Nuvalent acquisition. Learn about zidesamtinib & neladalkib, their clinical trial data, and the ROS1/ALK NSCLC competitive landscape.

40 min read

6/14/2026

gsk nuvalent zidesamtinib neladalkib nsclc ros1 inhibitor alk inhibitor precision oncology tyrosine kinase inhibitors

AI Foundation Models in Pharma: GSK-Noetik Oncology Deal

Examine the $50M GSK-Noetik agreement licensing AI foundation models for oncology. Learn how spatial biology and virtual cells advance R&D and drug discovery.

45 min read

4/17/2026

ai foundation models spatial biology drug discovery ai virtual cell models oncology research pharma ai nsclc colorectal cancer

Biomarker Testing Coordination Services: An Oncology Guide

Updated 2026 guide to biomarker testing coordination services in oncology. Covers navigator roles, FDA companion diagnostic reclassification, liquid biopsy adoption, NCCN guideline updates, and AI-driven diagnostics for precision medicine.

40 min read

11/16/2025

biomarker testing precision medicine oncology patient navigation lab coordination nsclc targeted therapy